Ronald Schnaar

Ronald Schnaar

Johns Hopkins University

H-index: 79

North America-United States

About Ronald Schnaar

Ronald Schnaar, With an exceptional h-index of 79 and a recent h-index of 40 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Glycobiology, neurobiology, inflammation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Sialyltransferase Mutations Alter the Expression of Calcium-Binding Interneurons in Mice Neocortex, Hippocampus and Striatum

Selective C-Br bond activation for decabromodiphenyl ether photo-debromination via sulfur vacancies enriched zinc indium sulfides

Gangliosides as Siglec ligands

Human sialoglycan ligands for immune inhibitory Siglecs

Cataloging natural sialic acids and other nonulosonic acids (NulOs), and their representation using the Symbol Nomenclature for Glycans

Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease

R-type Lectins

I-type Lectins

Ronald Schnaar Information

University

Position

Professsor of Pharmacology and Neuroscience School of Medicine

Citations(all)

26501

Citations(since 2020)

7357

Cited By

22099

hIndex(all)

79

hIndex(since 2020)

40

i10Index(all)

187

i10Index(since 2020)

102

Email

University Profile Page

Google Scholar

Ronald Schnaar Skills & Research Interests

Glycobiology

neurobiology

inflammation

Top articles of Ronald Schnaar

Sialyltransferase Mutations Alter the Expression of Calcium-Binding Interneurons in Mice Neocortex, Hippocampus and Striatum

International journal of molecular sciences

2023/12/7

Selective C-Br bond activation for decabromodiphenyl ether photo-debromination via sulfur vacancies enriched zinc indium sulfides

MOLECULAR ASPECTS OF MEDICINE

2023/4/1

Gangliosides as Siglec ligands

2023/4

Human sialoglycan ligands for immune inhibitory Siglecs

2023/4/1

Cataloging natural sialic acids and other nonulosonic acids (NulOs), and their representation using the Symbol Nomenclature for Glycans

Glycobiology

2023/2

Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease

Journal of Biological Chemistry

2023/1/1

R-type Lectins

2022

I-type Lectins

2022

Sialic acids and other nonulosonic acids

2022

Chemical tools for inhibiting glycosylation

2022

Glycans in Inflammation

2022/1/1

Discovery and classification of glycan-binding proteins

2022

Glycosphingolipids

The Role of Glycosylation in Health and Disease

2021

Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

Molecular neurodegeneration

2022/12/17

Bacterial and viral infections

2022/5/11

Plasma membrane calcium ATPase-neuroplastin complexes are selectively stabilized in GM1-containing lipid rafts

International Journal of Molecular Sciences

2021/1

Amyloid-beta and tau pathologies are both necessary to induce novel stage-specific microglia subtypes during Alzheimer’s disease progression

bioRxiv

2021/10/16

The crossroads of glycoscience, infection, and immunology

Frontiers in Microbiology

2021/9/27

Who's in, who's out? Re‐evaluation of lipid raft residents

Journal of neurochemistry

2021/8

See List of Professors in Ronald Schnaar University(Johns Hopkins University)